Data / Drug companies / Cholinergic Muscarinic Agonist
Cholinergic Muscarinic Agonist drugs: 2 drugs from 7 companies in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Cholinergic Muscarinic Agonist is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 25 products in this class from 7 companies, covering 2 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on June 30, 2025.
The request: Get every company that lists a Cholinergic Muscarinic Agonist drug in the FDA NDC directory, with headquarters, website and size. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 7Companies
- 25Products
- 2Drugs by generic name
Drugs in the Cholinergic Muscarinic Agonist class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Bethanechol chloride | 22 | 6 |
| Xanomeline and trospium chloride | 3 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amneal Pharmaceuticals LLC | 4 | tablet | Generic drugs (ANDA) | November 21, 2007 |
| Amneal Pharmaceuticals of New York LLC | 4 | tablet | Generic drugs (ANDA) | April 15, 2022 |
| Chartwell RX, LLC | 4 | tablet | Generic drugs (ANDA) | October 26, 2007 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | June 30, 2025 |
| Upsher-Smith Laboratories, LLC | 4 | tablet | Generic drugs (ANDA) | January 24, 2010 |
| E.r. Squibb & Sons, L.L.C. | 3 | capsule, coated pellets | New drug applications (NDA) | September 27, 2024 |
| American Health Packaging | 2 | tablet | Generic drugs (ANDA) | December 15, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 22 | 88% |
| Capsule, coated pellets | 3 | 12% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.